Alyeska Investment Group L.P. 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:25 pm Sale |
2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Alyeska Investment Group L.P. | 75,628 2.500% |
-180,780 (-70.50%) |
Filing |
| 2024-11-14 4:32 pm Purchase |
2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Alyeska Investment Group L.P. | 256,408 8.400% |
256,408 (New Position) |
Filing |